EFAVIRENZ 600 MG TABLET

Efavirenz
$1.4190per EA

Strength

600 mg/1

NDC

31722050430

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

EFAVIRENZ

Approval Type

Generic (ANDA)

FDA Application

ANDA078886

On Market Since

4/27/2018

Pharmacological Classes

Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inhibitors
Cytochrome P450 2C9 Inhibitors
Cytochrome P450 3A Inducers
Cytochrome P450 3A4 Inhibitors
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Non-Nucleoside Analog
Non-Nucleoside Reverse Transcriptase Inhibitors

Price History

1W

0.0%

1M

+3.9%

3M

+0.7%

6M

-18.5%

1Y

+7.4%

3Y

-54.0%

5Y

-79.8%

All

-94.8%